Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Programme

FP7
All
FP7-JTI (8)

Country

Austria (3)
Belgium (8)
Canada (1)
Denmark (2)
Finland (1)
France (8)
Germany (10)
Greece (1)
Israel (1)
Italy (3)
Luxembourg (2)
Netherlands (7)
Norway (2)
Singapore (1)
Spain (6)
Sweden (7)
Switzerland (7)
United Kingdom (8)
United States (3)

Language

English (8)

Advanced search

Results 1 - 8 of 8
Order by: Results/page:
1
Applied Public-Private Research enabling OsteoArthritis Clinical Headway
ID: 115770
Start date: 2015-06-01, End date: 2020-11-30
The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharmaceutical companies have de-emphasized or even abandoned OA drug development due to perceived hurdles. Crucial in this is the lack of ap...
Programme: FP7-JTI
Record Number: 203727
Last updated on: 2017-12-04
Intelligent Assessment of Pharmaceutical in the Environment
ID: 115735
Start date: 2015-01-01, End date: 2018-12-31
Active pharmaceutical ingredients (APIs) can be released to the natural environment during the manufacturing process, following use by patients or when unused medicines are disposed of. As APIs are biologically active compounds concerns have been raised about the potential ef...
Programme: FP7-JTI
Record Number: 203722
Last updated on: 2017-11-22
European Prevention of Alzheimer’s Dementia Consortium
ID: 115736
Start date: 2015-01-01, End date: 2019-12-31
Background: The secondary prevention of Alzheimer’s dementia (AD) is achievable if we can identify individuals at risk of disease progression defined by biomarker evidence of AD pathology and no or only minimal clinical symptoms and engage them in a standing adaptive clinical...
Programme: FP7-JTI
Record Number: 203723
Last updated on: 2017-11-20
iABC Programme
[PROJECT] IABC PROGRAMME - iABC Programme
ID: 115721
Start date: 2015-08-01, End date: 2021-12-31
Cystic Fibrosis (CF) is a common fatal inherited disease with a frequency of 1 in 2500 live births, affecting approximately 36,000 (0.737/10,000) people in the EU. Chronic bacterial pulmonary infection leading to an irreversible decline in lung structure and function is the m...
Programme: FP7-JTI
Record Number: 203721
Last updated on: 2017-11-20
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
ID: 115749
Start date: 2015-01-01, End date: 2019-12-31
Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential to improve the development of personalized medicines for cancer patients. This is of particular importance when biopsies of the primary ...
Programme: FP7-JTI
Record Number: 203725
Last updated on: 2017-11-20
Zoonotic Anticipation and Preparedness Initiative
ID: 115760
Start date: 2015-03-01, End date: 2020-02-29
Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on public and/or veterinary health as well as disruptive effects on sector, regional or even global economy. The predominantly zoonotic nature ...
Programme: FP7-JTI
Record Number: 203726
Last updated on: 2017-10-06
Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections
ID: 115737
Start date: 2015-01-01, End date: 2021-12-31
Antimicrobial resistance (AMR) is a major global public health threat, and most troublesome is the rapid emergence and dissemination of multidrug resistant (MDR) Enterobacteriaceae, Acinetobacter species and Pseudomonas aeruginosa. There is an unmet medical need to prevent P....
Programme: FP7-JTI
Record Number: 203724
Last updated on: 2017-08-27
Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery
ID: 115766
Start date: 2015-03-01, End date: 2020-02-29
ULTRA-DD (Unrestricted Leveraging of Targets for Research Advancement and Drug Discovery) will be an European-wide, highly collaborative and inclusive consortium, to validate new targets for drug discovery by (1) generating high quality research tools, with an emphasis on che...
Programme: FP7-JTI
Record Number: 203728
Last updated on: 2017-05-30
1
List retrieved on: 2018-11-18
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top